Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENS and Tadalafil in Erectile Dysfunction
NCT07574268Phase 4Completed
- Sponsor
- Menoufia University
- Start
- May 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tadalafil in erectile dysfunction (ED) (4 arms), sponsored by Menoufia University. Primary endpoints: Peak systolic volume at 3 months, End diastolic volume at 3 months and 1 more. Started May 2025; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07574268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07574268.